Otherside Farms
NOVEMBER 13, 2019
In actuality, experts project that the industry will be worth sixteen billion dollars by the end of 2025. In actuality, the condition gets agitated by anxiety, stress, and depression. CBD can calm epilepsy. The CBD business is growing at an alarming rate and with good reason. It is because. Cannabidiol Boosts Your Appetite.
Cannabis Law Report
JANUARY 12, 2020
It has approved use of cannabis extracts for treatment of a range of illnesses and conditions, including cancer, epilepsy, Alzheimer’s, Parkinson’s disease and anxiety. billion ($96 billion) by the end of 2025. Read more at [link].
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
FEBRUARY 18, 2020
Researchers predict that the market will be valued at $7 billion by the year 2025. And according to a Nielsen analytical report , the US market of legal marijuana will reach $41 billion in revenue by 2025, meaning that New York will make up close to 17% of the market share. In 2018, the New York legal cannabis market reached $1.8
Cannabis Law Report
SEPTEMBER 13, 2021
Commenting on the size and scope of the market for delaying aging, Dr. Chapman added, “There are no FDA-approved drugs for treating aging disorders and extending healthy lifespan in humans, a market expected to be at least $600 billion by 2025 1 according to a major investment bank.
Cannabis Law Report
JANUARY 5, 2022
3 MyMD believes that there are no FDA-approved drugs for treating aging disorders and extending healthy lifespan in humans, a market expected to be at least $600 billion by 2025 according to a major investment bank. The Company’s second drug platform, Supera-CBD , is being developed to treat chronic pain, addiction and epilepsy.
Cannabis Law Report
NOVEMBER 16, 2021
The market for treating aging disorders and extending healthy lifespan is expected to be at least $600 billion by 2025 1 according to a major investment bank. The Company’s second drug platform, Supera-CBD , is being developed to treat chronic pain, addiction and epilepsy.
Cannabis Law Report
OCTOBER 20, 2019
The pharmaceutical industry would likely have significant opportunities to develop new cannabinoid-based drugs for a multitude of medical conditions now being addressed by medical marijuana. billion in federal tax revenue between 2017 and 2025. as a Schedule II substance. xxv] [link]. xxvi] [link]. xxvii] [link]. xxviii] [link]. .
Expert insights. Personalized for you.
53 
Let's personalize your content